WASHINGTON — The Trump administration’s proposal to nearly eliminate funding for White House office tasked with overseeing the nation’s opioid fight is getting fast and firm pushback from the Senate.
A bipartisan group of 13 lawmakers, led by Senators Chuck Grassley (R-Iowa) and Dianne Feinstein (D-Calif.), warned President Trump this week that reducing the Office of National Drug Control Policy’s budget by nearly 95 percent would derail the fight against the opioid epidemic, hamper law enforcement efforts, and cost the government money in the long run.
About the Author Reprints
